...
首页> 外文期刊>Intensive Care Medicine Experimental >Pulmonary complement depositions in autopsy of critically ill patients have no relation with ARDS
【24h】

Pulmonary complement depositions in autopsy of critically ill patients have no relation with ARDS

机译:危重病患者的尸检中的肺补充沉积与ARDS无关

获取原文
           

摘要

BackgroundThe complement system has frequently been suggested to play a role in the pathophysiology of acute respiratory distress syndrome (ARDS). The current study explored the association between pulmonary depositions of a complement activation product and the clinical diagnosis of ARDS. MethodsLung tissue material from autopsied critically ill patients who died whilst on invasively mechanical ventilation was collected and stained for complement C3d. The diagnosis of ARDS was by the Berlin Definition. Lung injury scores (LIS) and driving pressures were calculated, 48 and 24?h prior to death. A pathologist who remained blinded for the clinical data scored the extent of C3d depositions, using a C3d deposition score (a minimum and maximum score of 0 and 24), and of diffuse alveolar damage (DAD). The primary analysis focused on the association between the C3d deposition score and the clinical diagnosis of ARDS. Secondary analyses focused on associations between the C3d deposition score and the presence of diffuse alveolar damage (DAD) in histopathology, and LIS and driving pressures in the last 2?days before death. ResultsOf 36 patients of whom autopsy material was available, 12 were diagnosed as having had ARDS. In all patients, C3d depositions were found in various parts of the lungs, and to a different extent. Notably, C3d deposition scores were similar for patients with ARDS and those without ARDS (4.5 [3.3–6.8] vs. 5.0 [4.0–6.0]; not significant ). C3d deposition scores were also independent from the presence or absence of DAD, and correlations between C3d scores and LIS and driving pressures prior to death were poor. ConclusionPulmonary C3d depositions are found in the lungs of all deceased ICU patients, independent of the diagnosis of ARDS. The presence of complement C3d was not associated with the presence of DAD on histopathology and had a poor correlation with ventilation characteristics prior to death.
机译:背景技术补充系统经常建议在急性呼吸窘迫综合征(ARDS)的病理生理学中发挥作用。目前的研究探讨了补体激活产品的肺部沉积与ARDS的临床诊断。方法收集尸体批判性患者的肺组织材料,染成侵入力机械通气的患者,并染色C3D。 ARDS的诊断是由柏林定义的。在死亡之前计算肺损伤分数(LIS)和驱动压力,48和24μm。使用C3D沉积得分(最小和最大得分为0和24),并且弥漫性肺泡损伤(爸爸),对临床数据保持盲目的病理学家。主要分析重点是C3D沉积得分与ARDS的临床诊断之间的关联。二次分析专注于C3D沉积得分与组织病理学中弥漫性肺泡损伤(爸爸)的关联,以及死亡前的最后2天的LIS和驱动压力。结果36名患者可用的尸检材料,12例被诊断为具有ARDS。在所有患者中,C3D沉积在肺的各个部位中发现,以及不同程度的沉积。值得注意的是,C3D沉积分数对于ARDS的患者和没有ARDS的患者(4.5 [3.3-6.8],5.0 [4.0-6.0];不显着)。 C3D沉积评分也与爸爸的存在或不存在无关,并且在死亡前C3D分数和LIS和驱动压力之间的相关性差。结论在所有已故的ICU患者的肺部发现玻术C3D沉积,与ARDS的诊断无关。补体C3D的存在与父亲对组织病理学的存在无关,并且在死亡前与通风特性具有较差的相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号